CryoPort Inc’s filing revealed that its Director Mandalam Ramkumar unloaded Company’s shares for reported $0.29 million on Jul 22 ’25. In the deal valued at $7.24 per share,40,728 shares were sold. As a result of this transaction, Mandalam Ramkumar now holds 92,328 shares worth roughly $0.75 million.
Then, RAMKUMAR MANDALAM bought 40,728 shares, generating $273,285 in total proceeds.
Before that, SHELTON JERRELL sold 16,344 shares. CryoPort Inc shares valued at $115,366 were divested by the President, CEO at a price of $7.06 per share. As a result of the transaction, SHELTON JERRELL now holds 912,419 shares, worth roughly $7.38 million.
Leerink Partners upgraded its CryoPort Inc [CYRX] rating to an Outperform from a a Market perform in a research note published recently. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who increased its forecast for the stock in early August from “a Sector weight” to “an Overweight”. UBS revised its rating on March 24, 2025. It rated CYRX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of CYRX
On Monday, CryoPort Inc [NASDAQ:CYRX] saw its stock jump 7.01% to $8.09. Over the last five days, the stock has gained 12.99%. CryoPort Inc shares have risen nearly 4.12% since the year began. Nevertheless, the stocks have risen 3.98% over the past one year. While a 52-week high of $9.66 was reached on 08/07/25, a 52-week low of $4.58 was recorded on 03/04/25.
Levels Of Support And Resistance For CYRX Stock
The 24-hour chart illustrates a support level at 7.69, which if violated will result in even more drops to 7.29. On the upside, there is a resistance level at 8.31. A further resistance level may holdings at 8.54.
How much short interest is there in CryoPort Inc?
A steep rise in short interest was recorded in CryoPort Inc stocks on 2025-07-15, growing by 0.26 million shares to a total of 2.7 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 2.44 million shares. There was a rise of 9.62%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 19, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
